Takeda
Clinical trials sponsored by Takeda, explained in plain language.
-
Second chance treatment tested for painful Crohn's complication
Disease control TerminatedThis study aimed to check the long-term safety and effectiveness of giving a second dose of a cell-based treatment called darvadstrocel to people with Crohn's disease who have complex, hard-to-heal fistulas around the anus. It involved about 53 participants who had already receiv…
Phase: PHASE4 • Sponsor: Takeda • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Stem cell shot tested to heal painful Crohn's complications in kids
Disease control TerminatedThis study tested a single injection of a stem cell treatment called darvadstrocel to see if it could help close complex perianal fistulas in children and teenagers with Crohn's disease. Participants first had minor surgery to clean the fistula, then received the injection. Resea…
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Extended safety testing for promising epilepsy drug in children
Disease control TerminatedThis study aimed to check the long-term safety of an experimental drug called soticlestat when added to existing seizure medications. It involved 156 children and young adults with severe, hard-to-treat forms of epilepsy, including Dravet and Lennox-Gastaut syndromes. Participant…
Phase: PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for kids battling leukemia that Won't quit
Disease control TerminatedThis study tested a drug called ponatinib, given with standard chemotherapy, for children and young adults up to age 21 with a specific type of leukemia that had come back or stopped responding to other treatments. The main goals were to find a safe dose and see if the combinatio…
Phase: PHASE1, PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New cancer drug trial tests immune system booster for tough tumors
Disease control TerminatedThis study tested a new drug called TAK-500, designed to activate the immune system to fight cancer. It was given alone or combined with an existing immunotherapy drug (pembrolizumab) to adults with advanced solid tumors that had stopped responding to standard treatments. The mai…
Phase: PHASE1, PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
New immune therapy tested for Tough-to-Treat cancers
Disease control TerminatedThis early-stage study tested a new drug called TAK-186 in adults with advanced cancers of the head & neck, lung, or colon that could not be removed by surgery. The main goal was to find a safe dose and understand the drug's side effects. Researchers also looked for early signs t…
Phase: PHASE1, PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Mar 12, 2026 13:52 UTC
-
Extended trial tests Add-On drug for severe childhood seizure disorders
Disease control TerminatedThis study aimed to check the long-term safety of an experimental drug called soticlestat when taken alongside standard medications. It involved about 352 children and adults with Dravet Syndrome or Lennox-Gastaut Syndrome, two rare and severe forms of epilepsy. The main goal was…
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Mar 09, 2026 14:23 UTC
-
New drug aims to prevent breathing problems after surgery for sleep apnea patients
Symptom relief TerminatedThis study tested whether a single dose of an experimental drug called danavorexton could help people with moderate to severe sleep apnea breathe more easily in the recovery room after abdominal surgery. The trial involved about 41 participants who were randomly assigned to recei…
Phase: PHASE2 • Sponsor: Takeda • Aim: Symptom relief
Last updated Mar 23, 2026 15:16 UTC
-
Scientists track cancer Drug's journey through the body
Knowledge-focused TerminatedThis early-stage study aimed to understand how the body absorbs, breaks down, and eliminates an experimental cancer drug called subasumstat in adults with advanced solid tumors. Participants received a single dose containing a tiny, safe amount of radioactive tracer to track the …
Phase: PHASE1 • Sponsor: Takeda • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:19 UTC